Keynote speaker (first session)
Namshik Han, Ph.D.
Head of Computational Research & AI, Milner Therapeutics Institute, University of Cambridge
Associate Faculty, Cambridge Centre for AI in Medicine, Department of Applied Mathematics and Theoretical Physics, University of Cambridge
Co-founder, KURE.ai and CardiaTec Biosciences
I am a computational drug discovery scientist, coming from a background in machine learning, computational biology, cancer genomics and cancer epigenomics. I am Head of Computational Research & AI at Milner Therapeutics Institute in University of Cambridge and also Associate Faculty at Cambridge Centre for AI in Medicine in the same University. My lab develop and apply dedicated and bespoke Artificial Intelligence technologies that deal with the uncertainty and complexity of biological datasets to reveal novel disease pathways and mechanisms. I also have an Adjunct Professor position at Yonsei University College of Medicine. In addition to my academic research, I have a passion for working at the interface between academia and industry to apply my research to real-world problems. In my case this is in therapeutics and patient care where AI promises to revolutionize the ability to identify disease mechanisms and potential drug targets, informing patient care from disease diagnosis through to treatment. Towards this aim, I facilitate access of the Milner Therapeutics Consortium partner organizations to cutting-edge AI technology and to develop new computational methods fulfilling the global mission of identifying new or better therapies from the analysis of biological data. Furthermore, I contributed to the establishment of Storm Therapeutics. I co-founded two start-ups: (1) KURE.ai to develop immune-oncology NK cell therapy and (2) CardiaTec to develop innovative drugs for cardiovascular diseases.
Keynote speaker (second session)
Enjung (Alice) Lee, Ph.D.
Assistant Professor, Boston Children’s Hospital and Harvard Medical School
Talk Title: Somatic mutation and repetitive DNA: the next frontier in human genomics
Dr. Lee is an Assistant Professor in the Division of Genetics and Genomics at Boston Children’s Hospital and Harvard Medical School, and an Associate Member of the Broad Institute. She is a faculty member of the Harvard Biomedical Informatics and Genomics (BIG) PhD Program. Her research is focused on somatic mutations and transposons in human health and disease using computational genomic and bioinformatic approaches. She is the recipient of the NIH Director's New Innovator Award (DP2), the SUHF Young Investigator Award, and a Charles Hood Foundation Research Award. She received her B.S. and M.S. in Computer Science and a Ph.D. in Bioinformatics mentored by Doheon Lee from KAIST (Korea Advanced Institute of Science and Technology). She also studied systems biology under the guidance of Trey Ideker at the University of California, San Diego during her Ph.D. studies. She then completed her postdoctoral training under the mentorship of Peter J. Park at Harvard Medical School.